MedTrace Logo

Side Effects of Newer Antipsychotics in Older Adults

NCT00245206 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 406

Last updated 2018-12-17

No results posted yet for this study

Summary

This study will compare four atypical antipsychotic medications in terms of the risk of specific side effects each of them presents in middle-aged and elderly individuals.

Conditions

Interventions

DRUG

Aripiprazole

Participant will take aripiprazole. Dosing will be determined by each participant's psychiatrist.

DRUG

Olanzapine

Participant will take olanzapine. Dosing will be determined by each participant's psychiatrist.

DRUG

Risperidone

Participant will take risperidone. Dosing will be determined by each participant's psychiatrist.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Veterans Medical Research Foundation

    lead OTHER

Principal Investigators

  • Dilip V. Jeste, MD · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245206 on ClinicalTrials.gov